We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$1.18B
AUM Growth
+$135M
Cap. Flow
+$141M
Cap. Flow %
11.99%
Top 10 Hldgs %
28.51%
Holding
522
New
58
Increased
52
Reduced
58
Closed
93

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$33.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$32.7M
3
V icon
Visa
V
+$30.2M
4
EXEL icon
Exelixis
EXEL
+$21.2M
5
TT icon
Trane Technologies
TT
+$20.6M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$6.85M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$6.7M
3
ARW icon
Arrow Electronics
ARW
+$6.63M
4
YPF icon
YPF
YPF
+$6.31M
5
SNPS icon
Synopsys
SNPS
+$6.28M

Sector Composition

Rank Sector Weight
1 Technology 23.9%
2 Healthcare 21.38%
3 Financials 15.14%
4 Consumer Discretionary 14.1%
5 Industrials 12.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
51
Mastercard
MA
$502B
$5.48M 0.46%
10,401
– –
CMCSA icon
52
Comcast
CMCSA
$85B
$5.42M 0.46%
144,457
– –
CRUS icon
53
Cirrus Logic
CRUS
$6.53B
$5.15M 0.44%
51,701
-4,573
-8% -$502K
JKHY icon
54
Jack Henry & Associates
JKHY
$10.9B
$5.05M 0.43%
28,781
+19,990
+227% +$3.57M
ITRI icon
55
Itron
ITRI
$4.36B
$5.04M 0.43%
46,455
– –
BLBD icon
56
Blue Bird Corp
BLBD
$2.35B
$4.99M 0.42%
129,190
– –
LYTS icon
57
LSI Industries
LYTS
$859M
$4.94M 0.42%
254,388
– –
PRGS icon
58
Progress Software
PRGS
$1.66B
$4.8M 0.41%
73,647
– –
YELP icon
59
Yelp
YELP
$1.45B
$4.79M 0.41%
123,880
+105,078
+559% +$3.83M
IQV icon
60
IQVIA
IQV
$38.7B
$4.79M 0.41%
24,357
+795
+3% +$168K
AXS icon
61
AXIS Capital
AXS
$7.68B
$4.76M 0.4%
53,758
– –
TOST icon
62
Toast
TOST
$18.7B
$4.74M 0.4%
129,970
+13,500
+12% +$474K
MWA icon
63
Mueller Water Products
MWA
$3.95B
$4.69M 0.4%
208,391
– –
FTDR icon
64
Frontdoor
FTDR
$5.1B
$4.63M 0.39%
84,749
-1,000
-1% -$54.2K
DXPE icon
65
DXP Enterprises
DXPE
$2.43B
$4.53M 0.38%
54,786
+6,923
+14% +$454K
PAYO icon
66
Payoneer
PAYO
$2.42B
$4.36M 0.37%
434,443
– –
PAHC icon
67
Phibro Animal Health
PAHC
$1.47B
$4.34M 0.37%
206,595
+1,700
+0.8% +$39.3K
MEDP icon
68
Medpace
MEDP
$16.1B
$4.3M 0.36%
12,949
– –
TCMD icon
69
Tactile Systems Technology
TCMD
$635M
$4.3M 0.36%
251,010
– –
DFIN icon
70
Donnelley Financial Solutions
DFIN
$1.16B
$4.3M 0.36%
68,494
– –
MRK icon
71
Merck
MRK
$322B
$4.2M 0.36%
42,212
-99
-0.2% -$10.2K
CPRX
72
DELISTED
Catalyst Pharmaceutical
CPRX
$4.07M 0.34%
194,786
+148,388
+320% +$3.19M
EHC icon
73
Encompass Health
EHC
$11B
$3.95M 0.33%
42,739
+32,200
+306% +$3.16M
P
74
Everpure Inc
P
$25.7B
$3.89M 0.33%
63,318
-39,771
-39% -$2.22M
UPWK icon
75
Upwork
UPWK
$1.13B
$3.88M 0.33%
237,562
+24,205
+11% +$349K
1 2
3
4 5

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Globeflex Capital held 522 positions worth $1.18B, up 13% from $1.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Globeflex Capital deployed $141M of net new capital in Q4 2024, opening 58 new positions and adding to 52 existing holdings. Its largest new stake was Bristol-Myers Squibb: 602,224 shares worth $34.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Arrow Electronics, an estimated $6.63M trimmed.

  • Globeflex Capital's largest Q4 2024 buy was Bristol-Myers Squibb: 602,224 shares worth $34.1M.
  • Globeflex Capital added most to Alphabet (Google) Class C in Q4 2024, an estimated $32.7M increase.
  • Globeflex Capital's biggest Q4 2024 reduction was Arrow Electronics, cutting an estimated $6.63M.
  • Globeflex Capital fully exited Hologic in Q4 2024, selling an estimated $6.85M.
  • Globeflex Capital's ten largest holdings make up 29% of its $1.18B portfolio in Q4 2024.
  • Globeflex Capital opened 58 new positions and closed 93 in Q4 2024.
  • Globeflex Capital's portfolio value rose 13% quarter-over-quarter to $1.18B.

Based on Globeflex Capital's 13F filing for Q4 2024, filed 10 Feb 2025.